Synthesis and binding affinity of 2-phenylimidazo[1,2-α]pyridine derivatives for both central and peripheral benzodiazepine receptors. A new series of high-affinity and selective ligands for the peripheral type

Journal of Medicinal Chemistry

Volumn 40, Issue 19, 1997, Pages 3109-3118

  Trapani, Giuseppe ^a   Franco, Massimo ^a   Ricciardi, Laura ^a   Latrofa, Andrea ^a   Genchi, Giuseppe ^a   Sanna, Enrico ^b   Tuveri, Francesca ^b   Cagetti, Elisabetta ^b   Biggio, Giovanni ^b   Liso, Gaetano ^a  

^a UNIVERSITY OF BARI   (Italy)

^b UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

2 PHENYLIMIDAZO[1,2A]PYRIDINE DERIVATIVE; ACETAMIDE; AMIDE; BENZODIAZEPINE RECEPTOR; PROPIONAMIDE DERIVATIVE; UNCLASSIFIED DRUG; ZOLPIDEM;

ARTICLE; BINDING AFFINITY; DRUG POTENCY; LIGAND BINDING; RECEPTOR AFFINITY; RECEPTOR BINDING; XENOPUS;

ANIMALS; BENZODIAZEPINONES; BINDING, COMPETITIVE; BRAIN; FEMALE; FLUNITRAZEPAM; HUMANS; HYPNOTICS AND SEDATIVES; IMIDAZOLES; KIDNEY; KINETICS; MALE; MITOCHONDRIA; MOLECULAR STRUCTURE; OOCYTES; PYRIDINES; RADIOLIGAND ASSAY; RATS; RATS, WISTAR; RECEPTORS, GABA-A; RECOMBINANT PROTEINS; STRUCTURE-ACTIVITY RELATIONSHIP; XENOPUS LAEVIS;

EID: 9844223397     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm970112+     Document Type: Article

References (48)

1. Squires, R. In GABA and Benzodiazepine Receptors; Squires, R., Ed.; CRC Press: Boca Raton, FL, 1988; Vols. 1-2.
2. - Ion Channels Modulated by Multiple Drug-Binding Sites. Trends Pharmacol. Sci. 1992, 13, 446-450.
3. A Receptor Structure and Function. J. Biol. Chem. 1992, 267, 16747-16750.
4. A Receptor Subtypes Really Occur in the Brain? Trends Neurosci. 1996, 19, 139-143.
5. Doble, A.; Martin, I. L. Multiple Benzodiazepine Receptors: No Reason for Anxiety. Trends Pharmacol. Sci. 1992, 13, 76-81.
6. Klepner, C. A.; Lippa, A. S.; Benson, D. I.; Sano, M. C.; Beer, B. Resolution of Two Biochemically and Pharmacologically Distinct Benzodiazepine Receptors. Pharmacol. Biochem. Behav. 1979, 11, 457-462.
7. Pritchett, D. B.; Luddens, H.; Seeburg, P. H. Type I and Type II GABA-A Benzodiazepine Receptors Produced by Transfected Cells. Science (Washington D.C.) 1989, 245, 1389-1392.
8. A Receptor Alpha 5-Subunit Creates Novel Type II Benzodiazepine Receptor Pharmacology. J. Neurochem. 1990, 54, 1802-1804.
9. Basile, A. S.; Skolnick, P. Subcellular Localization of "Peripheral-Type" Binding Sites for Benzodiazepines in Rat Brain. J. Neurochem. 1986, 46, 305-308.
10. O'Beirne, G. B.; Williams, D. C. The Subcellular Location in Rat Kidney of the Peripheral Benzodiazepine Receptors. Eur. J. Biochem. 1988, 175, 413-421.
11. (a)Anholt, R. R. H.; Pedersen, P. L.; De Souza, F. B.; Snyder, S. H. The Peripheral-Type Benzodiazepine Receptor. Localization to the Mitochondrial Outer Membranes. J. Biol. Chem. 1986, 261, 576-583.
12. (b) Hirsch J. B.; Beyer, C. F.; Malkowitz, L.; Louillis, C. C.; Blume, A. J. Characterization of Ligand Binding to Mitochondrial Benzodiazepine Receptors. Mol. Pharmacol. 1989, 35, 164-172.
13. (a)Kozikowski, A. P.; Ma, D.; Brewer, J.; Sun, S.; Costa, E.; Romeo, E.; Guidotti, A. Chemistry, Binding Affinity and Behavioral Properties of a New Class of "Antineophobic" Mitochondrial DBI Receptor Complex (mDRC) Ligands. J. Med. Chem. 1993, 36, 2908-2920.
14. (b) Baulieu, E.-E.; Robel, P. J. Neurosteroids: a New Brain Function? J. Steroid Biochem. Mol. Biol. 1990, 37, 395-403.
15. (a) George, P.; Rossey, G.; Depoortere, H.; Mompon, B.; Allen, J.; Wick. Imidazopyridines: Towards Novel Hypnotic and Anxiolytic Drugs. Il Farmaco 1991, 46, 277-288.
16. (b) Browne, L. J. and Shaw, K. J. New Anxiolytics. Annu. Rep. in Med. Chem. 1991, 26, 1-10.
17. (c) Dimsdale, M.; Friedmann, J.,C.; Morselli, P., L.; Zivkovic, B. Alpidem, Ananxyl. Drugs Future 1988, 13, 106-109.
18. 3 receptor subtypes. In GABA and Benzodiazepine Receptor Subtypes; Biggio,G., Costa, E., Eds.; Raven Press: New York, 1990; pp 61-72.
19. (e) Langer, S. Z.; Arbilla, S.; Lloyd, K. G.; George, P.; Allen, J.; Wick, A. Selectivity for Omega Receptor Subtypes as a Strategy for the Development of Anxiolytic Drugs. Pharmacopsychiatry 1990, 23, 103-107.
20. (a) Georges, G.; Vercauteren, D. P.; Vanderveken, D. J.; Horion, R.; Evrard, G. H.; Durant, F. V.; George, P.; Wick, A. E. Characterization of the Physico-Chemical Properties of the Imidazopyridine Derivative Alpidem. Comparison with Zolpidem. Eur. J. Med. Chem. 1993, 28, 323-335.
21. (b) George, P.; Rossey, G.; Depoortere, H.; Allen, J.; Wick, A. Le Zolpidem: un Nouvel Hypnotique de Structure Imidazo[1,2-α]Pyridine. (Topics in Med. Chem.) Act. Chim. Terap. 1991, 18, 215-239.
22. (c) Almirante, L.; Mugnaini, A.; Rugarli, P.; Gamba, A.; Zefilippo, E.; De Toma, N; Murmann, W. Derivatives of Imidazole. III. Synthesis and Pharmacological Activities of Nitriles, Amides, and Carboxylic Derivatives of Imidazo[1,2-α]Pyridine. J. Med. Chem. 1969, 12, 122-126.
23. (d) Abignente, E.; De Caprariis, P.; Fattorusso, E.; Mayol, L. Research on Heterocyclic Compounds.XXIIL Phenyl Derivatives of Fused Imidazole Systems. J. Heterocycl. Chem. 1989, 26, 1875-1880.
24. (e) Durand, A.; Thénot, J. P.; Bianchetti, G.; Morselli, P. L. Comparative Pharmacokinetic Profile of Two Imidazopyridine drugs: Zolpidem and Alpidem. Drug Metab. Rev. 1992, 24, 239-266.
25. Fryer, R. I. Ligand Interaction at the Benzodiazepine Receptor. In Comprehensive Medicinal Chemistry; Hansch, C., Sammes, P. G., Taylor, B., Eds.; C. A. Ramsden Pergamon Press: New York, 1990; Vol. 3, Chapter 12.8, pp 539-566 and references cited therein.
26. Huffman, J. A. A New Synthetic Route to Methoxytetralones. J. Org. Chem. 1959, 24, 1759-1763.
27. Tschitschibabin, A. E. Zur Tautomerie des α-Aminopyridine. (On the Tautomerism of 2-Aminopyridines.) Ber. 1925, 58, 1704-1706.
28. Laufer, S. A.; Augustin, J.; Dannhardt, G.; Kiefer,W. (6,7-Diaryldihydropyrrolyzin-5-yl)acetic Acids, a Novel Class of Potent Dual Inhibitors of both Cyclooxygenase and 5-Lipoxygenase. J. Med. Chem. 1994, 37, 1894-1897.
29. Belleau, B.; Martel, R.; Lacasse, G.; Menard, M.; Weinberg, N. L.; Perron, Y. C. N-Carboxylic Acid Esters of 1,2 and 1,4-Dihydroquinolines. A New Class of Irreversible Inactivators of the Catecholamine a Receptors and Potent Central Nervous System Depressants. J. Am. Chem. Soc. 1968, 90 823-824.
30. (a) Zhang, W.; Koehler, K. F.; Zhang, P.; Cook, J. M. Development of a Comprehensive Pharmacophore Model for the Benzodiazepine Receptor. Drug Des. Disc. 1995, 12, 193-248.
31. (b) Codding, P. W.; Muir, A. K. S. Molecular Structure of Ro15-1788 and a Model for the Binding of Benzodiazepine Receptor Ligands. Structural Identification of Common Features in Antagonists. Mol. Pharmacol. 1985, 28, 178-184.
32. (c) Borea, P. A.; Gilli, G.; Bertolasi, V.; Ferretti, V. Stereochemical Features Controlling Binding and Intrinsic Activity Properties of Benzodiazepine-Receptor Ligands. Mol. Pharmacol. 1987, 31, 334-344.
33. (d) Tebib, S.; Bourguignon, J.-J.; Wermuth, C.-G. The Active Analog Approach Applied to the Pharmacophore Identification of Benzodiazepine Receptor Ligands. J. Comput.-Aided Mol. Des. 1987, 1, 153-170.
34. (e) Villar, H. O.; Uyeno, E. T.; Toll, L.; Polgar, W.; Davies, M. F.; Loew, G. H. Molecular Determinants of Benzodiazepine Receptors Affinities and Anticonvulsant Activities. Mol. Pharmacol. 1989, 36, 589-600.
35. (f) Ghose, A. K.; Crippen, G. M. Modeling the Benzodiazepine Receptor Binding Site by the General Three-Dimensional, Structure-Directed Quantitative Structure-Activity Relationship Using REMOTE DISC. Mol. Pharmacol. 1990, 37, 725-734.
36. (a) Abraham, M. H.; Duce, P. P.; Prior, D. V.; Barratt, D. G.; Morris, J. J.; Taylor, P. J. Hydrogen Bonding. Part 9. Solute Proton Donor and Proton Acceptor Scales for Use in Drug Design. J. Chem. Soc., Perkin Trans. 2 1989, 1355-1375.
37. (b) Murray, J. S.; Ranganathan, S.; Politzer, P. Correlations Between the Solvent Hydrogen Bond Acceptor Parameter β and the Calculated Molecular Electrostatic Potential. J. Org. Chem. 1991, 56, 3734-3737.
38. (a) Anzini, M.; Cappelli, A.; Vomero, S.; Giorgi, G.; Langer, T.; Bruni, G.; Romeo, M. R.; Basile, A. S. Molecular Basis of Peripheral vs Central Benzodiazepine Receptor Selectivity in a New Class of Peripheral Benzodiazepine Receptor Ligands Related to Alpidem. J. Med. Chem. 1996, 39, 4275-4284.
39. (b) Lentini, G.; Bourguignon, J. J.; Wermuth, C. G. Ligands of the Peripheral-Type Benzodiazepine Binding Sites (PBS): Structure-Activity Relationships and Computer-Aided Conformational Analysis. In QSAR: Rational Approaches to the Design of Bioactive Compounds; Silipo, C., Vittoria, A., Eds.; Elsevier Science Publisher B.V.: Amsterdam, 1991; pp 257-260.
40. (c) Campiani, G.; Nacci, V.; Fiorini, I.; De Filippis, M. P.; Garofalo, A.; Ciani, S. M.; Greco, G.; Novellino, E.; Williams, D. C.; Zisterer, D. M.; Woods, M. J.; Mihai, C.; Manzoni, C.; Mennini, T. Synthesis, Biological Activity and SARs of Pyrrolobenzooxazepine Derivatives, A New Class of Specific "Peripheral-Type" Benzodiazepine Receptor Ligands. J. Med. Chem. 1996, 39, 3435-3450.
41. Wang, J. T.; Taniguchi, T.; Spector, S. Structural Requirements for the Binding of Benzodiazepines to their Peripheral-Type Sites. Mol. Pharmacol. 1984, 25, 349-351.
42. Bochis, R. J.; Dybas, R. A.; Eskola, P.; Kulsa, P.; Linn, B. O.; Lusi, A.; Meitzner, E. P.; Milkowski, J.; Mrozik, H.; Olen, L. E.; Peterson, L. H.; Tolman, R. L.; Wagner, A. F.; Waksmunski, F. S. Methyl 6-(phenylsulfinyl)imidazo[1,2-a]pyridine-2-carbamate, a Potent, New Anthelmintic. J. Med. Chem. 1978, 21, 235-237.
43. (a) Martini, C.; Giannacini, G.; Lucacchini, A. Solubilization of Rat Kidney Benzodiazepine Binding Sites. Biochim. Biophys. Acta 1985, 728, 289-292.
44. 3H]-Ro 5-4864 in Rat Brain and Kidney. J. Pharmacol. Exp. Ther. 1983, 225, 61-69.
45. Lowry, O. H.; Rosebrough, N. J.; Fair, A. L.; Randall, R. J. Protein Measurement with the Folin Phenol Reagent. J. Biol. Chem. 1951, 193, 265-275.
46. Munson, P. J.; Rodbard, D. Ligand: a Versatile Computerized Approach for Characterization of Ligand Binding Systems. Anal. Biochem. 1980, 107, 220-239.
47. Hadingham, K. L.; Wingrove, P. B.; Wafford, K. A.; Bain, C.; Kemp, J. A.; Palmer, K. J.; Wilson, A. W.; Wilcox, A. S.; Sikela, J. M.; Ragan, C. I.; Whiting, P. J. Role of the β Subunit in Determining the Pharmacology of Human γ-Aminobutyric Acid Type A Receptors. Mol. Pharmacol. 1993, 44, 1211-1218.
48. Dildy-Mayfield, J. E.; Harris, R. A. Comparison of Ethanol Sensitivity of Rat Brain Kainate, DL-α-Amino-3-hydroxy-5-methyl-4-isoxalone Propionic Acid And N-Methyl-D-aspartate Receptors Expressed In Xenopus Oocytes. J. Pharmacol. Exp. Ther. 1992, 262, 487-494.